Cardiol Therapeutics Inc. (TSX:CRDL)
2.700
-0.170 (-5.92%)
Aug 28, 2026, 4:00 PM EST
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-1.89M CAD
Market Cap
315.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Verano Holdings | 3,800 |
| Cresco Labs | 2,900 |
| Canopy Growth | 1,128 |
| Organigram Global | 1,120 |
| TerrAscend | 1,038 |
| Aurora Cannabis | 1,028 |
| Cannara Biotech | 452 |
| Auxly Cannabis Group | 446 |
Cardiol Therapeutics News
- 4 days ago - Cardiol Therapeutics initiated with a Buy at B. Riley - TheFly
- 13 days ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 13 days ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 13 days ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 18 days ago - Cardiol Therapeutics Registration statement: Q2 2026 - Filings
- 18 days ago - Cardiol Therapeutics Registration statement: Q2 2026 - Filings
- 18 days ago - Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial - MarketBeat
- 19 days ago - Cardiol Therapeutics Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts